During the past decade, Masaryk Hospital Usti nad Labem conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 10 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Masaryk Hospital Usti nad Labem" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Emergency Medical Service of the Central Bohemian Region, Czech Republic" with 6 trials sponsored, "Aesculap AG" with 1 trials sponsored, "Affectis Pharmaceuticals AG" with 1 trials sponsored and "Aposcience AG" with 1 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Masaryk Hospital Usti nad Labem" #1 collaborator was "Masaryk Hospital Usti nad Labem" with 5 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "FGK Clinical Research GmbH" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "AG Mednet Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Masaryk Hospital Usti nad Labem" are "Transthoracic Echocardiography" (4 trials), "Heart Failure" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Percutaneous Coronary Intervention" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Masaryk Hospital Usti nad Labem" in a lesser frequency.

Most popular intervention types in "Masaryk Hospital Usti nad Labem" are "Drug" (18 trials), "Diagnostic Test" (5 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Transthoracic echocardiography" (2 trials), "placebo" (2 trials) and "6-Mercaptopurine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Masaryk Hospital Usti nad Labem" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Masaryk Hospital Usti nad Labem". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Masaryk Hospital Usti nad Labem, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Masaryk Hospital Usti nad Labem, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".